Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology.

Behavioral similarity was only the starting point

O-6629 and O-6658 produced dose-dependent effects resembling parts of a cannabinoid test profile. Neither substituted for nor antagonized THC's discriminative stimulus. Drug discrimination measures learned responses to internal drug cues, rather than directly measuring human euphoria or addiction.

Several comparisons pointed toward distinct mechanisms

O-6658 substituted in mice trained with O-6629, while THC and morphine did not generate O-6629-like responding. Rimonabant did not block the O-6629 cue. Repeated THC also failed to produce cross-tolerance to O-6211 in the tested battery. Different analogues supplied different comparisons and should not be collapsed into one unnamed compound.

Abuse liability remained incompletely characterized

The authors suggested the analogues were unlikely to have marijuana-like abuse liability, but explicitly left general abuse liability undetermined. The mouse findings do not establish human safety or an absence of rewarding effects through other pathways. Their mechanisms were still under investigation.

The study distinguishes observable cannabinoid-like behaviors from THC-like cues and cross-tolerance. It supports careful pharmacological classification, not a blanket claim that these research compounds are safe or nonaddictive. The compound, endpoint and comparison drug must accompany the conclusion.

Related: interpreting cannabis tolerance claims.

Research cited

Walentiny D; Vann R; Mahadevan A; Kottani R; Gujjar R; Wiley J. Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice. British journal of pharmacology (2013). doi:10.1111/bph.12099. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

A female-rat feeding study found that THC increased fat intake in one access schedule while rimonabant reduced intake in another. The feeding history and experimental group mattered to the direction and persistence of the response. Limited access created different eating patterns Rats had unrestricted chow and water, with groups differing…

Spread the love

Read Article: THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

In a mouse THC study, mTOR inhibition prevented selected memory-related effects when given before exposure but did not prevent a residual cognitive deficit when introduced after chronic THC stopped. Timing changed the intervention's result. Acute effects separated by endpoint Temsirolimus prevented acute anxiety-like and amnesic-like effects. THC-related anxiolysis, hypothermia, reduced…

Spread the love

Read Article: mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule. Two disease-related models were used Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by…

Spread the love

Read Article: Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us